Self-powered platform holds promise as point-of-care biosensor

A single test strip - the first platform to couple a methanol fuel cell with a biosensor - could act as a self-powered, easy-to-use, disposable, and low-cost test for diseases such as cancer, say EU-funded researchers.

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Bosnia and Herzegovina
  Brazil
  Bulgaria
  Burkina Faso
  Cambodia
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czechia
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Faroe Islands
  Finland
  France
  French Polynesia
  Georgia

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Bosnia and Herzegovina
  Brazil
  Bulgaria
  Burkina Faso
  Cambodia
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czechia
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Faroe Islands
  Finland
  France
  French Polynesia
  Georgia


  Infocentre

Published: 13 May 2020  
Related theme(s) and subtheme(s)
Bioeconomy
EnergyRenewable energy sources
European Innovation Council (EIC) pilotEIC Pathfinder Pilot
Health & life sciencesBiotechnology  |  Drugs & drug processes  |  Major diseases  |  Medical research
Industrial researchMaterials & products
Information societyInformation technology
Innovation
Research policyHorizon 2020
Special CollectionsCancer
Countries involved in the project described in the article
Denmark  |  Finland  |  Portugal  |  United Kingdom
Add to PDF "basket"

Self-powered platform holds promise as point-of-care biosensor

Image

© Konstiantyn Zapylaie #209120253, source:stock.adobe.com 2020

Biosensors are designed to recognise specific target molecules (biomarkers) that indicate health conditions, such as cancer. However, the need to connect them to an energy source currently limits their potential use as point-of-care devices.

The EU-funded SYMBIOTIC project, which is supported through the European Innovation Council (EIC) Pathfinder research programme, previously FET Open, exploited previous research – which proved that methanol fuel cells can be fused with electrochemical biosensors – to create a simple, lightweight, low-cost, and completely self-powered prototype.

The novel self-powered platform – which combines a fuel cell with a biosensor in a single test-strip – could prove important in the detection and control of diseases, particularly in times of global crisis.

‘Our platform is very promising for applications in sensor devices since it has low energy demands and can be easily miniaturised,’ says project coordinator Goreti Sales, formerly of the Polytechnic Institute of Porto in Portugal, now based at the University of Coimbra in Portugal.

‘Although the idea is that each strip is used once, it can be reused several times whilst retaining its stability and performance, which is a novelty in this type of simple device.’

Working in synergy

SYMBIOTIC researchers created the prototype device from a single strip of cellulose paper which houses both the methanol fuel cell and the biosensing capability. The biosensing layer is inserted directly into the methanol fuel cell to become an integral part of it, responsible for converting chemical energy into electrical energy.

The fuel-cell anode is modified with a plastic antibody capable of recognising a protein biomarker. A few drops of a patient’s sample are placed on the strip. If this sample contains the biomarker of interest, this biomarker binds to the anode and creates an electrical change in the fuel cell to limit its efficiency.

The electrical signal obtained from the fuel cell is directly related to the concentration of the cancer biomarker in the sample.

The device is completely self-contained, operates autonomously at room temperature, and is fully passive, requiring only a tiny amount of aqueous methanol solution in combination with oxygen from the surrounding air.

The SYMBIOTIC platform could be used to detect a varied range of substances, from small molecules, such as amino acids, to more complex molecules, such as cancer biomarkers.

The research team also believe the innovative configuration of their device could be suitable as a micro fuel-cell system for a range of other portable applications that require a small power source.

A flexible platform

Since the project closed in 2018, PhD students Liliana Carneiro and Nádia Ferreira have been working on improving the current device. Making use of new processes for preparing the plastic antibodies, for example, would significantly lower costs and speed up production. Other ways of increasing the fuel cell’s efficiency are also under investigation.

‘Because this system does not require high power output and a continuous operation mode, the metallic catalysts we’ve employed could be replaced by other more widely available catalysts at a lower cost,’ adds Sales.

The platform has the potential to be used in the future for rapidly analysing patient samples anywhere, opening opportunities for the wider use of biosensors in global healthcare systems.

The EIC Pathfinder programme (FET Open) fosters novel ideas to support early-stage science and technology research in exploring new foundations for radically new future technologies.

Project details

  • Project acronym: SYMBIOTIC
  • Participants: Portugal (Coordinator), UK, Finland, Denmark
  • Project N°: 665046
  • Total costs: € 3 346 660
  • EU contribution: € 3 346 660
  • Duration: June 2015 to November 2018

See also

 

Convert article(s) to PDF

No article selected




loading
Print Version
Share this article
See also
Project details